NCT07609186 Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients
| NCT ID | NCT07609186 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Cataract |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-07 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-07 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effects of binaural beats on patient satisfaction and intraoperative comfort in patients aged 65 years or older undergoing cataract surgery (phacoemulsification and posterior chamber intraocular lens implantation) under monitored anesthesia care (MAC) with propofol. Participants are randomly assigned to either a binaural beat group or a control group. The binaural beat group will wear earphones and listen to binaural beats from the time they arrive at the operating room until the surgery is completed. The control group will wear identical earphones but will not receive any auditory stimulus. During the procedure, standard vital signs and the bispectral index (BIS) will be continuously monitored in both groups. Following the surgery, the investigators will assess the patients' overall satisfaction using a 7-point Likert scale. Secondary assessments include patient preference for the anesthesia method, intraoperative pain intensity, sedation level, anxiety level, and quality of life (EQ-VAS) measured by a visual analogue scale. Any surgery-related discomfort or adverse events will also be recorded and compared between the two groups.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled to undergo their first phacoemulsification and posterior chamber intraocular lens implantation (PE \& PCL) under monitored anesthesia care (MAC). * Patients aged 65 years or older. * Patients who fully understand the study and voluntarily provide written informed consent to participate. Exclusion Criteria: * Patients undergoing their second consecutive PE \& PCL surgery. * Patients with hearing loss, hearing impairment, or those who use hearing aids. * Patients unable to wear earphones due to diseases of the external auditory canal. * Patients who chronically use hypnotics or sedatives. * Patients with a history of obstructive sleep apnea or a Body Mass Index of 35 kg/m² or higher. * Patients with a history of alcohol or drug dependence. * Patients with a history of epilepsy or seizure disorders. * Patients who are unable to complete a written questionnaire. * Patients deemed unsuitable for participation in the clinical trial based on the investigator's clinical judgment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07609186 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07609186 currently recruiting?
Yes, NCT07609186 is actively recruiting participants. Contact the research team at eong77@snu.ac.kr for enrollment information.
Where is the NCT07609186 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07609186 clinical trial?
NCT07609186 is sponsored by Seoul National University Hospital. The trial plans to enroll 60 participants.